Angiotensin receptor neprilysin inhibitor as a novel antihypertensive drug: Evidence from Asia and around the globe

Hypertension is a worldwide epidemic that continues to grow, with a subset of patients responding poorly to current treatment available. This is especially relevant in Asia, which constitutes 61% of the global population. Hypertension in Asia is a unique entity that is often salt‐sensitive, nocturna...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Clin Hypertens (Greenwich)
Autori principali: Lin, Donna S.‐H., Wang, Tzung‐Dau, Buranakitjaroen, Peera, Chen, Chen‐Huan, Cheng, Hao‐Min, Chia, Yook Chin, Sukonthasarn, Apichard, Tay, Jam Chin, Teo, Boon Wee, Turana, Yuda, Wang, Ji‐Guang, Kario, Kazuomi
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2020
Soggetti:
Treatment and Management of Hypertension
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8029571/
https://ncbi.nlm.nih.gov/pubmed/33305531
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jch.14120
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi